We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$13.2M
2
TSLA icon
Tesla
TSLA
+$12.9M
3
BIDU icon
Baidu
BIDU
+$11.9M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10M
5
AMED
Amedisys
AMED
+$8.89M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACCO icon
1026
Acco Brands
ACCO
$402M
$121K 0.01%
30,400
– –
AIV
1027
Aimco
AIV
$377M
$120K 0.01%
15,097
-141,363
-90% -$1.15M
NRDS icon
1028
NerdWallet
NRDS
$645M
$119K 0.01%
+11,096
New +$118K
LAW icon
1029
CS Disco
LAW
$271M
$119K 0.01%
18,400
-900
-5% -$4.49K
GSM icon
1030
FerroAtlántica
GSM
$865M
$118K 0.01%
25,859
-15,023
-37% -$64.3K
KLC
1031
KinderCare Learning Companies
KLC
$596M
$117K 0.01%
17,611
+2,466
+16% +$20.7K
KYTX icon
1032
Kyverna Therapeutics
KYTX
$480M
$117K 0.01%
19,438
-16,809
-46% -$67.2K
JELD icon
1033
JELD-WEN Holding
JELD
$162M
$117K 0.01%
23,741
-7,459
-24% -$39.9K
AUTL
1034
Autolus Therapeutics
AUTL
$551M
$116K 0.01%
71,161
-38,266
-35% -$74.8K
ABUS icon
1035
Arbutus Biopharma
ABUS
$907M
$115K 0.01%
25,318
– –
PAMT
1036
PAMT Corp
PAMT
$287M
$114K 0.01%
10,000
– –
RYAM icon
1037
Rayonier Advanced Materials
RYAM
$593M
$113K 0.01%
15,672
-6,312
-29% -$32.5K
RERE
1038
ATRenew
RERE
$1.01B
$113K 0.01%
+24,523
New +$98.7K
TALO icon
1039
Talos Energy
TALO
$2.6B
$112K 0.01%
11,707
-22,500
-66% -$202K
REPL icon
1040
Replimune Group
REPL
$1.15B
$112K 0.01%
26,763
-97,017
-78% -$620K
RLGT icon
1041
Radiant Logistics
RLGT
$390M
$112K 0.01%
18,900
+700
+4% +$4.31K
PLX icon
1042
Protalix BioTherapeutics
PLX
$200M
$111K 0.01%
49,791
-6,264
-11% -$10.2K
TTI icon
1043
TETRA Technologies
TTI
$1.28B
$110K 0.01%
19,104
-41,655
-69% -$178K
ALM
1044
Almonty Industries
ALM
$3.89B
$109K 0.01%
+18,011
New +$81.9K
VIR icon
1045
Vir Biotechnology
VIR
$1.5B
$108K 0.01%
+19,000
New +$97.2K
GRNT icon
1046
Granite Ridge Resources
GRNT
$670M
$106K 0.01%
19,600
+8,600
+78% +$46.9K
TG icon
1047
Tredegar Corp
TG
$292M
$105K 0.01%
+13,134
New +$108K
SEER icon
1048
Seer Inc
SEER
$119M
$104K 0.01%
47,937
-2,684
-5% -$5.71K
STLA icon
1049
Stellantis
STLA
$21B
$104K 0.01%
+11,107
New +$106K
CALY
1050
Callaway Golf Company
CALY
$3.04B
$103K 0.01%
10,850
-4,250
-28% -$39.5K
40 41
42
43 44

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.